Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study.
about
Medical treatments for endometriosis-associated pelvic painEmerging therapy for endometriosisReevaluating response and failure of medical treatment of endometriosis: a systematic review.Expected Next-Generation Drugs Under Development in Relation to Voiding SymptomsInnovations in classical hormonal targets for endometriosis.Endometriosis: alternative methods of medical treatment.An update on the pharmacological management of adenomyosis.Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.Endometriosis: bright future for a cloudy past?Minimising menopausal side effects whilst treating endometriosis and fibroids.Advances in pharmacotherapy for treating endometriosis.An overview of early drug development for endometriosis.GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Overview of elagolix for the treatment of endometriosis.Pharmacological Management of Chronic Pelvic Pain in Women.Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.Elagolix: a promising oral GnRH antagonist for endometriosis-associated pain.Recent Development of Non-Peptide GnRH Antagonists.Efficacy of elagolix in the treatment of endometriosis.New insights on the pathogenesis of endometriosis and novel non-surgical therapies
P2860
Q26991844-5701CD03-5FB5-4E25-BEBC-8540EE8FF11EQ28262987-EF4DEFD4-3DAC-43C0-A64A-227CFC5F224FQ33862947-99C3D017-1783-4AC1-BA8D-47520F70E13AQ33871856-E5DA5D83-80F8-42D9-9562-176BA3D061A2Q34504377-780F22E8-B904-404B-8F14-EC72CBEBA3DBQ35668144-E899E966-02A1-4F50-9ABE-853E509E1A46Q38246723-988C2F5D-F42C-4A1C-8867-2EF3A9306035Q38315212-CEF131E3-423D-44D8-BFEE-9678EEE4B49EQ38327403-E51CD8ED-7B24-4FF5-8D66-0EFA9633860BQ38388553-2493E10F-CC99-47F9-9FD7-041C75E6C2B5Q38633773-9A7FBFED-4EEC-43B8-A326-71B61F233D78Q38653393-5186757F-6FEE-485C-86BF-F3ABC3792541Q38682630-3B1E9371-225D-4F5A-95A2-45447C6465A7Q38791644-81B277FA-304E-40DB-8F2F-80EDB65C8995Q39078993-4BE9951A-5382-4691-A19F-10201384EFBEQ39159286-870C75D9-6E98-43D4-9040-C795AF061F32Q47141718-BC765AAA-2DE4-4102-AFC0-C95E5BB1B11BQ47323557-C61AB6A1-6749-4C80-AF8B-06809A3B8E20Q50874818-1EFD7BEB-6B26-4E48-86C0-79F976654739Q58799203-FCD18074-4D97-4B65-B856-FB6950E37F11
P2860
Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@ast
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@en
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@nl
type
label
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@ast
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@en
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@nl
prefLabel
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@ast
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@en
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@nl
P2093
P2860
P356
P1476
Elagolix treatment for endomet ...... ind, placebo-controlled study.
@en
P2093
Bruce Carr
Chris O'Brien
Elizabeth Garner
Joshua Burke
Kristof Chwalisz
Ping Jiang
Roland Jimenez
W Paul Dmowski
William Koltun
P2860
P304
P356
10.1177/1933719113497292
P577
2013-07-24T00:00:00Z